Key Technical Fields Listed

WASHINGTON—The future of America's economy depends in large measure on the ability of industry to exploit new and emerging technologies, according to a new Commerce Department study. The report, prepared by experts from the National Bureau of Standards and other Commerce agencies, identifies seven major groups of emerging technologies that they believe will result in new products or processes in the next century. These include advanced materials, electronics, automation, biotechnology, co

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The report, prepared by experts from the National Bureau of Standards and other Commerce agencies, identifies seven major groups of emerging technologies that they believe will result in new products or processes in the next century. These include advanced materials, electronics, automation, biotechnology, computing, medical technology and thin-layer technology.

Some of these already are in commercial development: high-performance ceramics, advanced microelectronics, supercomputers and genetically engineered drugs and chemicals. Others will require substantially greater R&D efforts before reaching the market.

Clarence J. Brown, deputy secretary of commerce, said that such constraints as the high cost of capital, less favorable tax incentives, and industry's inability to adopt long-range goals are among the barriers impeding exploitation of emerging technologies. Other barriers, he said, include inadequate protection for U.S. intellectual property rights and restrictive ex port regulations.

The House Appropriations Committee on June 25 voted a 13 percent increase in NSF's budget for fiscal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies